Loading...
SciClone Pharmaceuticals, Inc.
SCLN•NASDAQ
$11.15
$0.00(0.00%)
SciClone Pharmaceuticals, Inc. (SCLN) Company Profile & Overview
Explore SciClone Pharmaceuticals, Inc.’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.
SciClone Pharmaceuticals, Inc. (SCLN) Company Profile & Overview
SciClone Pharmaceuticals, Inc. is a global biopharmaceutical company. The Company acquires, develops, and commercializes drugs for treating chronic and life-threatening diseases such as cancer, hepatitis B, hepatitis C, cystic fibrosis, and immune system disorders.
Company Facts
IPO DateMar 17, 1992